Intracranial Aneurysm Market Growth Opportunities and Forecast till 2030
The Global Intracranial Aneurysm Market Size valued for USD 1.2 Billion in 2021 and is anticipated to reach USD 2.6 Billion by 2030 with a CAGR of 9.2% from 2022 to 2030.
A bulge or ballooning in a blood vessel inside the brain is called an intracranial aneurysm (AN-yoo-riz-um). A berry hanging on a stem is a common representation of an aneurysm. A ruptured or leaking intracranial aneurysm could result in brain bleeding (hemorrhagic stroke). A ruptured brain aneurysm typically develops between the brain and the delicate tissues that cover the brain. A subarachnoid haemorrhage is the medical term for this kind of hemorrhagic stroke. Aneurysms in the posterior circulation, including those in the posterior communicating artery, basilar artery, and vertebral arteries, are more likely to burst. Even though they make up only 3-5% of all intracranial aneurysms, basilar artery aneurysms are the most prevalent in the posterior circulation.
Parameter |
Intracranial Aneurysm Market |
Intracranial Aneurysm Market Size in 2021 |
US$ 1.22 Billion |
Intracranial Aneurysm Market Forecast By 2030 |
US$ 2.63 Billion |
Intracranial Aneurysm Market CAGR During 2022 – 2030 |
9.2% |
Intracranial Aneurysm Market Analysis Period |
2018 - 2030 |
Intracranial Aneurysm Market Base Year |
2021 |
Intracranial Aneurysm Market Forecast Data |
2022 - 2030 |
Segments Covered |
By Type, By End-Use, and By Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
B. Braun, Codman Neuro (Integra Lifesciences), Johnson and Johnson Services Inc., Medtronic plc, Microport Scientific Corporation, MicroVention Inc. (Terumo Corporation), RAUMEDIC AG, and Stryker Corporation. |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Intracranial Aneurysm Market Dynamics
The market is expanding as a result of the increasing incidence of brain aneurysms and the release of cutting-edge products on the market. The increased spending on healthcare solutions and the rising demand for minimally invasive procedures are driving the market's expansion. The market value is further expanding due to the major players' and government authorities' increased R&D efforts. Additionally, it is anticipated that over the forecast period of 2022 to 2030, ongoing efforts to develop affordable solutions and growing awareness of the treatment will create potential opportunities.
With a prevalence of about 4%, intracranial aneurysms are comparatively common. Aneurysms that have not ruptured may still cause symptoms primarily as a result of a mass effect, but the real danger comes from when an aneurysm ruptures and causes a subarachnoid haemorrhage. The majority of aneurysms is asymptomatic and won't burst, but because of how unpredictable they grow, even small aneurysms are at risk of doing so. Imaging techniques such as intra-arterial digital subtraction angiography, magnetic resonance angiography, computed tomography angiography, and most recently transcranial Doppler ultrasonography have been proposed as a potential modality are used to diagnose and monitor intracranial aneurysms. Surgery clipping, endovascular coiling, and observation are all possible treatments.
Intracranial Aneurysm Market Insights
The global intracranial aneurysm market is split on the type, end-use, and geography.
The type segment is further split into surgical clipping, endovascular coiling, flow diverters, and others. Among them, endovascular coiling sub-segment accounted for majority of the share. However, the surgical clipping sub-segment is anticipated to attain the quickest CAGR during the forecast period from 2022 to 2030.
End-use segment is sub-segment into hospitals & clinics, ambulatory surgical centers, and others. Hospitals and clinics are the market's dominant category globally and are predicted to grow rapidly over the next few years, according to the intracranial aneurysm market forecast. The segmental market value is being supported by the availability of technologically sophisticated infrastructure and skilled professionals. During the anticipated period from 2022 to 2030, the segmental market value will be significantly impacted by the growing number of hospitals on the global market, particularly in developing economies worldwide.
Global Intracranial Aneurysm Market Geographical Competition
The North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa regions make up the five geographical segments of the global Intracranial Aneurysm market. The intracranial aneurysm market in North America recorded the highest revenue share in 2021, and the region is expected to continue to dominate the market from 2022 to 2030. The value of the regional market is being supported by the presence of significant international players. In 2021, the region's two largest economies—the US and Canada—will contribute the majority of the region's revenues. The value of the regional market is increasing as a result of ongoing technological advancements in the product portfolio of the major players and the presence of a population base with high incomes.
Global Intracranial Aneurysm Industry Segment Analysis
Intracranial Aneurysm Market By Type
· Surgical Clipping
· Endovascular Coiling
· Flow Diverters
· Others
Intracranial Aneurysm Market By End-Use
· Hospitals & Clinics
· Ambulatory Surgical Centers
· Others
Intracranial Aneurysm Market Leading Companies
This section of the study honors the market's top vendors B. Braun, Codman Neuro (Integra Lifesciences), Johnson and Johnson Services Inc., Medtronic plc, Microport Scientific Corporation, MicroVention Inc. (Terumo Corporation), RAUMEDIC AG, and Stryker Corporation.
Intracranial Aneurysm Market Regions
North America
· U.S.
· Canada
Europe
· U.K.
· Germany
· France
· Spain
· Rest of Europe
Latin America
· Brazil
· Mexico
· Rest of Latin America
Asia-Pacific
· China
· Japan
· India
· Australia
· South Korea
· Rest of Asia-Pacific
Middle East & Africa
· GCC
· South Africa
· Rest of Middle East & Africa